← Leaderboards
Daniel J Lindner
Cleveland Clinic Foundation
$2,056,260
Attributed
$2,056,260
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $523.3K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,056,260 · 2
By mechanism
R01$2,056,260 · 2
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Taolin Yi$3,372,347
Others in their field
Top investigators on “Athymic Mouse”
- Thomas F Deuel · Beth Israel Deaconess Medical Center$7,283,721
- Ralph Weissleder · Massachusetts General Hospital$5,688,124
- Donald P McDonnell · Duke University$5,386,390
- Oliver W. Press · Fred Hutchinson Cancer Research Center$5,178,285
- Channing J Der · University Of North Carolina Chapel Hill$4,926,790
- Murray Korc · University Of California Irvine$4,764,672
Research focus
Athymic MouseEnzyme Induction /RepressionInterferon BetaApoptosisNeoplastic Cell Culture For Noncancer ResearchEnzyme ActivityGenetic RegulationSds Polyacrylamide Gel ElectrophoresisProtein KinaseTerminal Nick End LabelingNucleic Acid SequencePolymerase Chain ReactionCell Growth RegulationCell LineInositol PhosphatesImmunoprecipitationNeoplastic ProcessFlow CytometryFluorescence MicroscopyCobalaminDrug Screening /EvaluationGel Mobility Shift AssayNuclear Factor Kappa BetaThin Layer Chromatography
Grant awards (8)
Nitrosylcobalamin - A Novel Chemotherapeutic Agent$237,918
R01 · FY2007 · CA · contact PI
Inositol hexakisphosphate kinase 2:apoptosis regulator$265,940
R01 · FY2006 · CA · contact PI
Nitrosylcobalamin - A Novel Chemotherapeutic Agent$245,023
R01 · FY2006 · CA · contact PI
Inositol hexakisphosphate kinase 2:apoptosis regulator$272,340
R01 · FY2005 · CA
Nitrosylcobalamin - A Novel Chemotherapeutic Agent$250,920
R01 · FY2005 · CA
Inositol hexakisphosphate kinase 2:apoptosis regulator$272,340
R01 · FY2004 · CA
Nitrosylcobalamin - A Novel Chemotherapeutic Agent$250,920
R01 · FY2004 · CA
Inositol hexakisphosphate kinase 2:apoptosis regulator$260,859
R01 · FY2003 · CA